Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/ fallopian tube/ primary peritoneal carcinoma (EOC) treatment

Andrew R. Clamp, Jonathan A. Ledermann, Adrian Cook et al.|Annals of Oncology|2018

Cited by 5